Last 12 months
Inside the activity.
0 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 15, 2013 Filed Apr 16, 2013 20:35 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
SaleCommon Stock | 34,422 | $57.34 | $1,973,757.48 |
DisclosureSEC source: 0001127602-13-013975 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,061.1502 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 15, 2013 Filed Apr 16, 2013 20:35 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
Exercise / conversionCommon Stock | 34,422 | $36.23 | $1,247,109.06 |
DisclosureSEC source: 0001127602-13-013975 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,483.1502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:15 UTC |
MERLO LARRY JDirector · President and CEO
|
GrantStock Option · Derivative | 314,713 | $54.53 Strike: $54.53 | $17,161,299.89 |
DisclosureSEC source: 0001127602-13-013242 · form4.xml · derivative · entry 6 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,713 Underlying: Common Stock · 314,713 shares Expires 2020-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:15 UTC |
MERLO LARRY JDirector · President and CEO
|
GrantCommon Stock (restricted) | 73,355 | $54.53 | $4,000,048.15 |
DisclosureSEC source: 0001127602-13-013242 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,753 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2016 and 50% on 4/1/2018. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:21 UTC |
Denton David MEVP, CFO
|
GrantStock Option · Derivative | 108,183 | $54.53 Strike: $54.53 | $5,899,218.99 |
DisclosureSEC source: 0001127602-13-013254 · form4.xml · derivative · entry 5 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,183 Underlying: Common Stock · 108,183 shares Expires 2020-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:21 UTC |
Denton David MEVP, CFO
|
Tax withholdingCommon Stock | 1,919 | $54.53 | $104,643.07 |
DisclosureSEC source: 0001127602-13-013254 · form4.xml · nonDerivative · entry 3 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,316.0559 F2 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:21 UTC |
Denton David MEVP, CFO
|
Tax withholdingCommon Stock | 2,067 | $54.53 | $112,713.51 |
DisclosureSEC source: 0001127602-13-013254 · form4.xml · nonDerivative · entry 2 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,316.0559 F2 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:21 UTC |
Denton David MEVP, CFO
|
GrantCommon Stock (restricted) | 25,216 | $54.53 | $1,375,028.48 |
DisclosureSEC source: 0001127602-13-013254 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,869 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/12016 and 50% on 4/1/2018. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:23 UTC |
Roberts Jonathan CEVP & President, Caremark
|
GrantStock Option · Derivative | 68,844 | $54.53 Strike: $54.53 | $3,754,063.32 |
DisclosureSEC source: 0001127602-13-013257 · form4.xml · derivative · entry 6 Roberts Jonathan C · CIK 0001410515 · EVP & President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,844 Underlying: Common Stock · 68,844 shares Expires 2020-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:23 UTC |
Roberts Jonathan CEVP & President, Caremark
|
Tax withholdingCommon Stock | 5,822 | $54.53 | $317,473.66 |
DisclosureSEC source: 0001127602-13-013257 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · EVP & President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,078.6731 F2 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:23 UTC |
Roberts Jonathan CEVP & President, Caremark
|
GrantCommon Stock (restricted) | 16,047 | $54.53 | $875,042.91 |
DisclosureSEC source: 0001127602-13-013257 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,333 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2016 and 50% on 4/1/2018. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:25 UTC |
COSBY MARKEVP & President-CVS/pharmacy
|
GrantStock Option · Derivative | 59,009 | $54.53 Strike: $54.53 | $3,217,760.77 |
DisclosureSEC source: 0001127602-13-013261 · form4.xml · derivative · entry 3 COSBY MARK · CIK 0001214180 · EVP & President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,009 Underlying: Common Stock · 59,009 shares Expires 2020-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:25 UTC |
COSBY MARKEVP & President-CVS/pharmacy
|
GrantCommon Stock (restricted) | 13,754 | $54.53 | $750,005.62 |
DisclosureSEC source: 0001127602-13-013261 · form4.xml · nonDerivative · entry 1 COSBY MARK · CIK 0001214180 · EVP & President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,318 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2016 and 50% on 4/1/2018. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:29 UTC |
Moriarty Thomas MEVP & General Counsel
|
GrantStock Option · Derivative | 49,174 | $54.53 Strike: $54.53 | $2,681,458.22 |
DisclosureSEC source: 0001127602-13-013266 · form4.xml · derivative · entry 4 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,174 Underlying: Common Stock · 49,174 shares Expires 2020-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:29 UTC |
Moriarty Thomas MEVP & General Counsel
|
GrantCommon Stock (restricted) | 11,462 | $54.53 | $625,022.86 |
DisclosureSEC source: 0001127602-13-013266 · form4.xml · nonDerivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,462 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2016 and 50% on 4/1/2018. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:31 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
GrantStock Option · Derivative | 47,207 | $54.53 Strike: $54.53 | $2,574,197.71 |
DisclosureSEC source: 0001127602-13-013269 · form4.xml · derivative · entry 4 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,207 Underlying: Common Stock · 47,207 shares Expires 2020-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:31 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
Tax withholdingCommon Stock | 2,233 | $54.53 | $121,765.49 |
DisclosureSEC source: 0001127602-13-013269 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,061.1502 Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:31 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
GrantCommon Stock (restricted) | 11,004 | $54.53 | $600,048.12 |
DisclosureSEC source: 0001127602-13-013269 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,919 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2016 and 50% on 4/1/2018. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:35 UTC |
Foulkes HelenaExecutive Vice President
|
GrantStock Option · Derivative | 39,340 | $54.53 Strike: $54.53 | $2,145,210.20 |
DisclosureSEC source: 0001127602-13-013274 · form4.xml · derivative · entry 6 Foulkes Helena · CIK 0001429996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,340 Underlying: Common Stock · 39,340 shares Expires 2020-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:35 UTC |
Foulkes HelenaExecutive Vice President
|
Tax withholdingCommon Stock | 1,157 | $54.53 | $63,091.21 |
DisclosureSEC source: 0001127602-13-013274 · form4.xml · nonDerivative · entry 2 Foulkes Helena · CIK 0001429996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,816.6021 F2 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:35 UTC |
Foulkes HelenaExecutive Vice President
|
GrantCommon Stock (restricted) | 9,170 | $54.53 | $500,040.10 |
DisclosureSEC source: 0001127602-13-013274 · form4.xml · nonDerivative · entry 1 Foulkes Helena · CIK 0001429996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,113 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2016 and 50% on 4/1/2018. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:38 UTC |
Bisaccia LisaSVP, Chief HR Officer
|
GrantStock Option · Derivative | 27,538 | $54.53 Strike: $54.53 | $1,501,647.14 |
DisclosureSEC source: 0001127602-13-013280 · form4.xml · derivative · entry 5 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,538 Underlying: Common Stock · 27,538 shares Expires 2020-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:38 UTC |
Bisaccia LisaSVP, Chief HR Officer
|
GrantCommon Stock (restricted) | 6,419 | $54.53 | $350,028.07 |
DisclosureSEC source: 0001127602-13-013280 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,128.0004 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2016 and 50% on 4/1/2018. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:41 UTC |
GOLD STEPHEN JSVP & CIO
|
GrantStock Option · Derivative | 25,571 | $54.53 Strike: $54.53 | $1,394,386.63 |
DisclosureSEC source: 0001127602-13-013287 · form4.xml · derivative · entry 4 GOLD STEPHEN J · CIK 0001252005 · SVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,571 Underlying: Common Stock · 25,571 shares Expires 2020-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:41 UTC |
GOLD STEPHEN JSVP & CIO
|
GrantCommon Stock (restricted) | 5,961 | $54.53 | $325,053.33 |
DisclosureSEC source: 0001127602-13-013287 · form4.xml · nonDerivative · entry 1 GOLD STEPHEN J · CIK 0001252005 · SVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,961 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2016 and 50% on 4/1/2018. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:43 UTC |
Joyner J. DavidEVP, Sales & Account Services
|
GrantStock Option · Derivative | 23,604 | $54.53 Strike: $54.53 | $1,287,126.12 |
DisclosureSEC source: 0001127602-13-013289 · form4.xml · derivative · entry 3 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,604 Underlying: Common Stock · 23,604 shares Expires 2020-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:43 UTC |
Joyner J. DavidEVP, Sales & Account Services
|
Tax withholdingCommon Stock | 2,342 | $54.53 | $127,709.26 |
DisclosureSEC source: 0001127602-13-013289 · form4.xml · nonDerivative · entry 2 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,540 F2 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:43 UTC |
Joyner J. DavidEVP, Sales & Account Services
|
GrantCommon Stock (restricted) | 5,502 | $54.53 | $300,024.06 |
DisclosureSEC source: 0001127602-13-013289 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,772 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2016 and 50% on 4/1/2018. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:46 UTC |
Sussman AndrewSVP & President, MinuteClinic
|
GrantStock Option · Derivative | 23,604 | $54.53 Strike: $54.53 | $1,287,126.12 |
DisclosureSEC source: 0001127602-13-013292 · form4.xml · derivative · entry 5 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,604 Underlying: Common Stock · 23,604 shares Expires 2020-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:46 UTC |
Sussman AndrewSVP & President, MinuteClinic
|
GrantCommon Stock (restricted) | 5,502 | $54.53 | $300,024.06 |
DisclosureSEC source: 0001127602-13-013292 · form4.xml · nonDerivative · entry 1 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,701 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2016 and 50% on 4/1/2018. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:52 UTC |
Daniels LairdSVP, Cont & Chief Acct Officer
|
GrantStock Option · Derivative | 19,670 | $54.53 Strike: $54.53 | $1,072,605.10 |
DisclosureSEC source: 0001127602-13-013302 · form4.xml · derivative · entry 4 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,670 Underlying: Common Stock · 19,670 shares Expires 2020-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:52 UTC |
Daniels LairdSVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock | 445 | $54.53 | $24,265.85 |
DisclosureSEC source: 0001127602-13-013302 · form4.xml · nonDerivative · entry 2 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,845.1281 F2 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:52 UTC |
Daniels LairdSVP, Cont & Chief Acct Officer
|
GrantCommon Stock (restricted) | 4,585 | $54.53 | $250,020.05 |
DisclosureSEC source: 0001127602-13-013302 · form4.xml · nonDerivative · entry 1 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,489 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2016 and 50% on 4/1/2018. Read SEC document |
| March 29, 2013 Filed Apr 1, 2013 19:21 UTC |
WELDON WILLIAM CDirector
|
GrantCommon Stock | 591 | $54.99 | $32,499.09 |
DisclosureSEC source: 0001127602-13-012483 · form4.xml · nonDerivative · entry 1 WELDON WILLIAM C · CIK 0001189019 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,591 F1 · shares: Consists of common stock issued as a pro rata portion of the retainer payable for the Reporting Person's 2013 Board Service. Read SEC document |
| March 19, 2013 Filed Mar 20, 2013 20:20 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
Exercise / conversionStock Option · Derivative | 6,222 | $0.00 Strike: $36.23 | $0.00 |
DisclosureSEC source: 0001127602-13-011524 · form4.xml · derivative · entry 8 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,845 Underlying: Common Stock · 6,222 shares Expires 2017-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2011. Read SEC document |
| March 19, 2013 Filed Mar 20, 2013 20:20 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
SaleCommon Stock | 6,222 | $54.00 | $335,988.00 |
DisclosureSEC source: 0001127602-13-011524 · form4.xml · nonDerivative · entry 4 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,636.1502 F1 · shares: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| March 19, 2013 Filed Mar 20, 2013 20:20 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
Exercise / conversionCommon Stock | 6,222 | $36.23 | $225,423.06 |
DisclosureSEC source: 0001127602-13-011524 · form4.xml · nonDerivative · entry 3 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,858.1502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 18, 2013 Filed Mar 20, 2013 20:20 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
Exercise / conversionStock Option · Derivative | 28,200 | $0.00 Strike: $36.23 | $0.00 |
DisclosureSEC source: 0001127602-13-011524 · form4.xml · derivative · entry 7 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,067 Underlying: Common Stock · 28,200 shares Expires 2017-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2011. Read SEC document |
| March 18, 2013 Filed Mar 20, 2013 20:20 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
SaleCommon Stock | 28,200 | $54.00 | $1,522,800.00 |
DisclosureSEC source: 0001127602-13-011524 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,636.1502 F1 · shares: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| March 18, 2013 Filed Mar 20, 2013 20:20 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
Exercise / conversionCommon Stock | 28,200 | $36.23 | $1,021,686.00 |
DisclosureSEC source: 0001127602-13-011524 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,836.1502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2013 Filed Mar 6, 2013 21:05 UTC |
Denton David MEVP, CFO
|
Tax withholdingCommon Stock | 632 | $52.30 | $33,053.60 |
DisclosureSEC source: 0001127602-13-009602 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,985.0559 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| February 19, 2013 Filed Feb 21, 2013 21:46 UTC |
Denton David MEVP, CFO
|
GrantCommon Stock | 7,947 | $52.66 | $418,489.02 |
DisclosureSEC source: 0001127602-13-007321 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,300 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan. Read SEC document |
| February 19, 2013 Filed Feb 21, 2013 21:49 UTC |
Bisaccia LisaSVP, Chief HR Officer
|
GrantCommon Stock | 4,768 | $52.66 | $251,082.88 |
DisclosureSEC source: 0001127602-13-007328 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,476 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan. Read SEC document |
| February 19, 2013 Filed Feb 21, 2013 21:48 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
GrantCommon Stock | 7,549 | $52.66 | $397,530.34 |
DisclosureSEC source: 0001127602-13-007325 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,636.1502 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan. Read SEC document |
| February 19, 2013 Filed Feb 21, 2013 21:51 UTC |
Foulkes HelenaExecutive Vice President
|
GrantCommon Stock | 6,357 | $52.66 | $334,759.62 |
DisclosureSEC source: 0001127602-13-007330 · form4.xml · nonDerivative · entry 1 Foulkes Helena · CIK 0001429996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,558.6021 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan. Read SEC document |
| February 19, 2013 Filed Feb 21, 2013 21:53 UTC |
MERLO LARRY JDirector · President and CEO
|
GrantStock Unit | 26,225 | $52.66 | $1,381,008.50 |
DisclosureSEC source: 0001127602-13-007331 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,483.0949 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| February 19, 2013 Filed Feb 21, 2013 21:54 UTC |
Roberts Jonathan CEVP & President, Caremark
|
GrantStock Unit | 9,536 | $52.66 | $502,165.76 |
DisclosureSEC source: 0001127602-13-007332 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,384.6748 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| February 19, 2013 Filed Feb 21, 2013 21:59 UTC |
Lofberg Per GHEVP and President, Caremark
|
GrantStock Unit | 28,484 | $52.66 | $1,499,967.44 |
DisclosureSEC source: 0001127602-13-007333 · form4.xml · nonDerivative · entry 1 Lofberg Per GH · CIK 0001318289 · EVP and President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,454.4303 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| February 19, 2013 Filed Feb 28, 2013 20:55 UTC |
Daniels LairdSVP, Cont & Chief Acct Officer
|
GrantCommon Stock (restricted) | 4,273 | $52.66 | $225,016.18 |
DisclosureSEC source: 0001127602-13-008496 · form4.xml · nonDerivative · entry 1 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,239 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing February 19, 2014. Read SEC document |
| February 17, 2013 Filed Feb 19, 2013 21:14 UTC |
Bisaccia LisaSVP, Chief HR Officer
|
Tax withholdingCommon Stock | 293 | $51.12 | $14,978.16 |
DisclosureSEC source: 0001127602-13-006736 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,708 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.